These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Atypical parathyroid adenomas: challenging lesions in the differential diagnosis of endocrine tumors. Cetani F; Marcocci C; Torregrossa L; Pardi E Endocr Relat Cancer; 2019 Jul; 26(7):R441-R464. PubMed ID: 31085770 [TBL] [Abstract][Full Text] [Related]
26. MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism. Cetani F; Pardi E; Vignali E; Borsari S; Picone A; Cianferotti L; Ambrogini E; Miccoli P; Pinchera A; Marcocci C J Endocrinol Invest; 2002 Jun; 25(6):508-12. PubMed ID: 12109621 [TBL] [Abstract][Full Text] [Related]
27. CTNNB1 mutations in basal cell adenoma of the salivary gland. Lee YH; Huang WC; Hsieh MS J Formos Med Assoc; 2018 Oct; 117(10):894-901. PubMed ID: 29224720 [TBL] [Abstract][Full Text] [Related]
30. An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT/beta-catenin signaling. Björklund P; Akerström G; Westin G PLoS Med; 2007 Nov; 4(11):e328. PubMed ID: 18044981 [TBL] [Abstract][Full Text] [Related]
31. Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors? Dotzenrath C; Teh BT; Farnebo F; Cupisti K; Svensson A; Toell A; Goretzki P; Larsson C J Clin Endocrinol Metab; 1996 Sep; 81(9):3194-6. PubMed ID: 8784068 [TBL] [Abstract][Full Text] [Related]
32. Familial hyperparathyroidism. Burden RP Proc R Soc Med; 1971 Oct; 64(10):1067-8. PubMed ID: 5145323 [No Abstract] [Full Text] [Related]
33. Upregulation of FGFR1 expression is associated with parathyroid carcinogenesis in HPT-JT syndrome due to an HRPT2 splicing mutation. Lee JY; Kim SY; Mo EY; Kim ES; Han JH; Maeng LS; Lee AH; Eun JW; Nam SW; Moon SD Int J Oncol; 2014 Aug; 45(2):641-50. PubMed ID: 24889687 [TBL] [Abstract][Full Text] [Related]
34. Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective. Rao DS; Agarwal G; Talpos GB; Phillips ER; Bandeira F; Mishra SK; Mithal A J Bone Miner Res; 2002 Nov; 17 Suppl 2():N75-80. PubMed ID: 12412781 [TBL] [Abstract][Full Text] [Related]
35. CTNNB1 (beta-catenin) mutation is rare in brain tumours but involved as a sporadic event in a brain metastasis. Lee CI; Hsu MY; Chou CH; Wang C; Lo YS; Loh JK; Howng SL; Hong YR Acta Neurochir (Wien); 2009 Sep; 151(9):1107-11. PubMed ID: 19582367 [TBL] [Abstract][Full Text] [Related]
37. Bilateral neck exploration for primary hyperparathyroidism. Nottingham JM; Brown JJ; Bynoe RP; Bell RM; Haynes JL Am Surg; 1993 Feb; 59(2):115-9. PubMed ID: 8476140 [TBL] [Abstract][Full Text] [Related]
38. A case of familial isolated hyperparathyroidism with ectopic parathyroid cancer. Yamashita K; Suzuki S; Yumita W; Ikeo Y; Uehara Y; Minemura K; Sakurai A; Hashizume K Endocr J; 2001 Aug; 48(4):453-8. PubMed ID: 11603567 [TBL] [Abstract][Full Text] [Related]
39. [Recurrent familial hyperparathyroidism. A propos of 7 adenomas in 3 members of the same family. Review of the literature]. Doury P; Eulry F; Pattin S; Fromantin M; Gautier D; Bernard J; Tabaraud F; Masson C; Dano P Sem Hop; 1983 Dec; 59(49):3427-30. PubMed ID: 6320421 [TBL] [Abstract][Full Text] [Related]
40. [A combination of ectopic parathyroid adenoma and thalassemia with manifestations of extreme hyperparathyroidism]. Lozanov B; Mendizov I; Dzherov D; Chavrakov G; Sarafova A Vutr Boles; 1989; 28(1):97-100. PubMed ID: 2741449 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]